Fragment-based drug discovery and biological evaluation of novel cannabinol-based inhibitors of oxytosis/ferroptosis for neurological disorders is a research paper published in Redox Biology (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: P30 AG068635
NIH HHS
Grant: S10 OD021815
NIA NIH HHS
Grant: R01 AG069206
NIA NIH HHS
Grant: R21 AG064287
NIA NIH HHS
Grant: R01 AG067331
NIA NIH HHS
Grant: R21 AG067334
NIA NIH HHS
Grant: RF1 AG061296
National Institutes of Health
Grant: 5R01AG067331-02
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease
National Institutes of Health
Grant: 5R01AG069206-02
Using geroscience to understand and treat Alzheimer's disease
National Institutes of Health
Grant: 1RF1AG061296-01A1
The Contribution of Kidney Disease to Age-Associated Cognitive Decline
National Institutes of Health
Grant: 1R21AG064287-01A1
Therapeutic Relevance of Cannabinoids for Alzheimer's Disease
National Institutes of Health
Grant: 1S10OD021815-01
A Hybrid Quadrupole-Orbitrap LC/MS
National Institutes of Health
Grant: 5R21AG067334-02
Neural Aging and A Toxicity Assessments, a Fly Pharmacology-Molecular AD Model
National Institutes of Health
Grant: 3P30AG068635-03S1
San Diego Nathan Shock Center
Glenn Foundation for Medical Research
National Cancer Institute
Shiley Foundation
National Institute on Aging
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals